Information and interesting ideas

Topics posted here will be in the realm of bioanalysis and biomarkers as part of new therapeutic development, with the occasional post of scientific topics that I find interesting.

Monday, February 6, 2023

Biomarker Article Reading for the Week

Analytical and Bioanalytical Chemistry. Volume 415, Issue 6 is now available online and brings together a number of articles on biomarkers using different technologies. Many are focused on solutions supporting personalized medicine. I’ve downloaded a number of them (titles and authors below) for reading this week.

 

Electrochemical biosensors — driving personalized medicine

Maria Jesús Lobo-Castañón, Susana Campuzano

 

Detection of COVID-19-related biomarkers by electrochemical biosensors and potential for diagnosis, prognosis, and prediction of the course of the disease in the context of personalized medicine

Viviana Vásquez, Jahir Orozco

 

Point-of-care electrochemical testing of biomarkers involved in inflammatory and inflammatory-associated medical conditions

Diana-Gabriela Macovei, Maria-Bianca Irimes, Oana Hosu, Cecilia Cristea, Mihaela Tertis

 

Electrochemical biosensors for analysis of DNA point mutations in cancer research

Katerina Ondraskova, Ravery Sebuyoya, Ludmila Moranova, Jitka Holcakova, Petr Vonka, Roman Hrstka, Martin Bartosik

 

Practical tips and new trends in electrochemical biosensing of cancer-related extracellular vesicles

Patrick Severin Sfragano, Serena Pillozzi, Gerolama Condorelli, Ilaria Palchetti

 

An ultrasensitive and disposable electrochemical aptasensor for prostate-specific antigen (PSA) detection in real serum samples

Canan Özyurt, İnci Uludağ, Mustafa Kemal Sezgintürk

 

Accelerating the development of implantable neurochemical biosensors by using existing clinically applied depth electrodes

Alexander R. Macdonald, Francessca Charlton, Damion K. Corrigan


No comments:

Post a Comment

FDA and CMS issue statement on LDTs: Americans Deserve Accurate and Reliable Diagnostic Tests, Wherever They Are Made

This joint statement notes the evolution of Laboratory Developed Tests (LDTs) from the initial rule and approach the FDA had for oversite, a...